Federal Register / Vol. 77, No. 4 / Friday, January 6, 2012 / Notices 797 

Dated: December 19, 2011. 

Sherry Glied, 

Assistant Secretary for Planning and 

Evaluation. 

[FR Doc. 2012–30 Filed 1–5–12; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health Statement 

of Organization, Functions, and 

Delegations of Authority 

Part N, National Institutes of Health 

(NIH), of the Statement of Organization, 

Functions, and Delegations of Authority 

for the Department of Health and 

Human Services (40 FR 22859, May 27, 

1975, as amended most recently at 66 

FR 6617, January 22, 2001, and 

redesignated from Part HN as Part N at 

60 FR 56605, November 9, 1995), is 

amended as set forth below to establish 

the National Center for Advancing 

Translational Science (NCATS), to 

abolish the National Center for Research 

Review (NCRR), and to establish 

organizational components within 

National Institute of General Medical 

Sciences (NIGMS), National Institute on 

Minority Health and Health Disparities 

(NIMHD) and the NIH Office of the 

Director (OD). 

Section N–8, Organization and 

Functions, is amended as follows: 

Immediately after the paragraph headed 

‘‘Division of Program Coordination and 

Integration’’ (N 875, formerly HN 875), 

insert the following: 

National Center for Advancing 

Translational Sciences (NCATS) (N 9, 

formerly HN 9) (1) Provides leadership 

for a national program to advance the 

discipline of translational science and 

catalyze the generation of innovative 

methods and technologies that will 

enhance the development, testing, and 

implementation of diagnostics and 

therapeutics across a wide range of 

human diseases and conditions; (2) 

conducts intramural research; (3) 

supports and coordinates research 

projects through research grants, 

contracts, and other mechanisms; (4) 

supports training in translational 

sciences; (5) collaborates with 

organizations and other institutions 

engaged in translational research and 

training activities; and (6) collects and 

disseminates research findings and 

related information. 

Office of the Director (OD) (N 91, 

formerly HN 91) (1) Develops and 

provides leadership for the Center’s 

translational science programs; (2) 

manages and directs executive-level 

activities and functions; (3) provides 

policy guidance and overall operational 

coordination for the organizational units 

within NCATS; and (4) manages critical 

points of contact and related 

information flows to respond to external 

inquiries. 

Division of Pre-Clinical Innovation 

(DPI) (N 92, formerly HN 92) (1) Plans, 

conducts, and supports research across 

the pre-clinical phases of the 

translational science spectrum; (2) 

plans, conducts, and supports research 

to develop new methods and 

technologies to enhance pre-clinical 

processes; (3) plans, conducts, and 

supports research to evaluate existing 

and developing approaches, 

technologies, and processes in the preclinical spectrum; (4) supports training 

programs relevant to pre-clinical phases 

of translational science; (5) allocates 

resources to pre-clinical extramural and 

intramural investigators; (6) collaborates 

with ICs and the scientists they support; 

and (7) consults with stakeholders, 

including patients, industry, and 

regulators. 

Division of Clinical Innovation (DCI) 

(N 93, formerly HN 93) (1) Plans, 

conducts, and supports research across 

the clinical phases of the translational 

science spectrum; (2) plans, conducts, 

and supports research to develop new 

methods and technologies to enhance 

clinical processes; (3) plans, conducts, 

and supports research to evaluate 

existing and developing approaches, 

technologies, and processes in the 

clinical spectrum; (4) supports training 

programs relevant to clinical phases of 

translational science; (5) allocates 

resources to clinical extramural and 

intramural investigators; (6) collaborates 

with ICs and the scientists they support; 

and (7) consults with stakeholders, 

including patients, industry, and 

regulators. 

Executive Office (EO) (N 912, 

formerly HN 912) (1) Directs the 

administrative management and 

financial management operations of 

NCATS; (2) develops, administers, and 

directs NCATS’ internal control 

processes; (3) oversees development of 

and administers NCATS policies and 

procedures for administrative, program 

management, and information 

technology activities; and (4) oversees 

personnel management and workforce 

planning. 

Office of Grants Management and 

Scientific Review (OGMSR) (N 913, 

formerly, HN 913) (1) Provides advice 

and assistance to the Director of 

NCATS, NCATS Division Directors, and 

other NCATS officials on issues related 

to policy and procedures for extramural 

activities; (2) provides oversight and 

direction for scientific review and grants 

management activities of NCATS; (3) 

coordinates NCATS small business 

research programs and other special 

grants programs; (4) manages the 

operations of the national advisory 

council for NCATS; and (5) provides 

coordination, support, and staff services 

for committee management. 

Office of Rare Diseases Research 

(ORDR) (N 914, formerly, HN 914) (1) 

Guides and coordinates NIH-wide 

activities involving research into 

combating and treating the broad array 

of rare (orphan) diseases; (2) manages 

the NIH Rare Diseases and Orphan 

Products Coordinating Committee 

(Trans-NIH Rare Diseases Working 

Group); (3) develops and maintains a 

centralized database on rare diseases; (4) 

coordinates and provides liaison with 

Federal and non-Federal national and 

international organizations concerned 

with rare disease research and orphan 

products development; (5) advises the 

OD/NIH on matters relating to NIHsponsored research activities that 

involve rare diseases and conditions; 

and (6) responds to requests for 

information on highly technical matters 

and matters of public policy relative to 

rare diseases and orphan products. 

Office of Policy, Communications, 

and Strategic Alliances (OPCSA) (N 915, 

formerly, HN 915) (1) Provides 

leadership and direction to the 

planning, coordinating, reporting, 

analytical, evaluative, and legislative 

functions that support NCATS program 

development, science policy 

formulation, and overall program 

direction and decision-making activities 

of the NCATS executive staff; (2) 

advises the NCATS Director on policy 

matters pertaining to NCATS scientific 

programs; (3) communicates 

information about NCATS programs and 

accomplishments to a wide range of 

audiences; (4) advises the NCATS 

Director on effective communications 

strategies; (5) fosters relationships and 

partnerships with stakeholders; (6) 

assists in the development of content for 

internal and external Web sites and 

audiences; (7) develops and executes a 

strategy for education and training for 

the disciplines that constitute 

translational science; (8) facilitates and 

supports partnerships with NIH OD, 

other ICs, patient groups, other 

governmental agencies, nonprofits and 

the private sector to achieve the goals of 

the Center; and (9) oversees and 

manages NCATS technology transfer 

activities including overseeing NCATS 

intellectual property, patent, and 

licensing agreement portfolios. 

Section N–D, Organization and 

Functions, is amended as follows: 

Immediately after the paragraph headed 


pmangrum on DSK3VPTVN1PROD with NOTICES
798 Federal Register / Vol. 77, No. 4 / Friday, January 6, 2012 / Notices 

‘‘Office of Grants Management’’ (N D43, 

formerly HN D43), insert the following: 

Office of Research Training and 

Capacity Building (ORTCB) (N E32, 

formerly HN E32) (1) Plans, designs, 

develops and manages a diverse 

portfolio of training and career 

development programs and activities; 

(2) plans, develops, coordinates, 

supports and manages programs to 

expand the Nation’s capacity to conduct 

research at institutions conducting and/ 

or interested in minority health and 

health disparities research; (3) provides 

technical assistance to faculty, 

institutions, community groups and 

other organizations conducting and/or 

interested in minority health and health 

disparities research; and (4) provides 

support to improve, through 

construction, facilities conducting 

biomedical and behavioral research on 

minority health and health disparities. 

Office of Innovation and Program 

Coordination (ORIPC) (N E33, formerly 

HN E33) (1) Plans, stimulates, develops 

and supports a broad extramural 

research program to include basic, 

behavioral and clinical research on 

minority health and health disparity 

conditions including research to 

prevent, diagnose and treat such 

conditions; (2) develops innovative 

research programs and projects for the 

Institute that link the biological and 

non-biological determinants of health; 

and (3) works with the Office of the 

Director to coordinate inter- and intraagency programs and projects on 

minority health and health disparities. 

Section N–R, Organization and 

Functions, is amended as follows: 

Immediately after the paragraph headed 

‘‘Division of Research Infrastructure’’ (N 

RL, formerly HN RL), insert the 

following: 

Division of Training, Workforce 

Development, and Diversity (DTWDD) 

(N S5, formerly HN S5) (1) Serves as the 

focal point for the Institute’s efforts to 

foster research training and facilitate the 

development of a diverse and inclusive 

biomedical research workforce; (2) 

oversees and coordinates NIGMS 

policies related to diversity activities, 

research training programs, and 

workforce development efforts; (3) 

implements strategic plans to improve 

the effectiveness of NIGMS’ diversity 

and training programs; (4) promotes 

biomedical research workforce diversity 

through innovative approaches, 

including programs to increase the 

competitiveness of faculty at 

institutions from states with limited 

NIH research support; and (5) 

collaborates with NIH, DHHS, and other 

agencies, as well as the extramural 

scientific community on these matters. 

Division of Biomedical Technology, 

Bioinformatics, and Computational 

Biology (DBTBCB) (N S7, formerly HN 

S7) (1) Plans, directs, and administers a 

program of research grants, contracts, 

and other funding mechanisms to 

support research and research training 

in data management, analysis and 

visualization, computational modeling 

and analysis of systems and networks, 

including biostatistical analyses, as well 

as the development of new or improved 

technologies—in areas such as high 

performance computing, molecular 

imaging, structural biology and 

proteomics—which will be applied to 

advance biomedical research; (2) defines 

the Institute’s needs for database 

development and applications, as well 

as collaborates with other NIH 

components and federal agencies in 

developing policies in this area; (3) 

coordinates the activities of the 

Biomedical Information Science and 

Technology Initiative (BISTI) and the 

trans-NIH Biomedical Information 

Science and Technology Initiative 

Committee (BISTIC) with related 

activities of other federal agencies, NIH 

institutes, and public and private 

entities; (4) analyzes national research 

efforts directed toward the study of the 

above and makes recommendations to 

assist the National Advisory General 

Medical Sciences Council or other 

advisory committees or appointed 

groups to (a) participate in decisions 

about new or continuing areas of 

program emphasis, or (b) determine the 

relative scientific merit of applications 

for grant support; (5) maintains 

surveillance over new research 

developments and identifies the need 

for research in the areas of 

computational analysis of biological 

systems at the cellular, subcellular, 

physiological and population systems 

levels, as well as innovative 

technologies and instrumentation for 

biomedical research which could be 

used by a wide range of biomedical or 

clinical researchers and not limited to a 

specific organ or disease; and (6) 

provides information to third parties 

such as universities, other centers of 

biomedical research, and professional 

and lay organizations about research 

needs and requirements of the Division. 

Section N–AW, Organization and 

Functions, is amended as follows: 

Immediately after the paragraph headed 

‘‘Office of Grants Management’’ (N AV5, 

formerly HN AV5), insert the following: 

Division of Program Coordination, 

Planning, and Strategic Initiatives 

(DPCPSI) (N AW, formerly HN AW) (1) 

Identifies, reports on, and provides 

support for research that represents 

important areas of emerging scientific 

opportunities, rising public health 

challenges, or knowledge gaps that 

deserve special emphasis and would 

benefit from conducting or supporting 

additional research that involves 

collaboration between two or more 

Institutes and Centers (ICs), or would 

otherwise benefit from strategic 

coordination and planning; (2) 

coordinates and provides support for 

research and activities related to AIDS, 

behavioral and social sciences, women’s 

health, disease prevention, and dietary 

supplements; (3) applies resources 

(databases, analytic tools, and 

methodologies) and develops 

specifications for new resources in 

support of portfolio analyses and 

priority setting in scientific areas of 

interest across NIH; (4) engages in 

activities designed to ensure that NIH 

addresses important areas of emerging 

scientific opportunities and public 

health challenges effectively; (5) plans, 

conducts, coordinates, and supports 

program evaluations and coordinates 

and prepares reports required by the 

Government Performance and Results 

Modernization Act and related 

performance management initiatives; (6) 

provides animal models, supports the 

identification and development of new 

and improved animal models for the 

study of human diseases, provides 

repositories for the storage and 

distribution of genetically altered 

animal models, and supports 

specialized animal research facilities for 

biomedical investigators; (7) supports 

the development of research models; (8) 

supports research activities at National 

Primate Research Centers; (9) provides 

oversight for the NIH Chimpanzee 

Management Program (ChiMP) and 

provides a chimpanzee sanctuary for the 

lifetime care of research chimpanzees 

that are no longer needed for biomedical 

research; (10) supports the improvement 

of the health and well-being of 

laboratory animals; (11) supports the 

breeding of and accessibility to scarce 

research animals; (12) supports training 

and career development for 

veterinarians engaged in research; (13) 

provides access for biomedical 

researchers to an array of biological 

materials and human biospecimens; (14) 

provides support to improve biomedical 

and behavioral research facilities 

through construction and renovation; 

and (15) plans, develops, coordinates, 

and provides support for a science 

education program to improve science 

literacy in adults and children and to 

attract young people to biomedical and 

behavioral science careers. 

Office of Research Infrastructure 

Programs (ORIP) (N AW9, formerly HN 


pmangrum on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 4 / Friday, January 6, 2012 / Notices 799 

AW9) (1) Provides support for resource 

activities and research to identify, 

develop, characterize, and improve 

animal models for the study of human 

disease; (2) assists institutions in 

complying with the regulations and 

policies related to care and use of 

laboratory animals, and supports the 

purchase of equipment for animal 

resources, transgenic animal resources, 

and similar activities; (3) provides highquality, disease-free animal models and 

specialized animal research facilities for 

biomedical investigators; (4) supports 

the development of and access to a wide 

range of research models, including 

vertebrate and invertebrate species; (5) 

provides access for biomedical 

researchers to an array of biological 

materials and human biospecimens; (6) 

supports research activities at National 

Primate Research Centers; (7) develops 

and implements policies and provides 

programmatic oversight for the NIH 

Chimpanzee Management Program 

(ChiMP); (8) provides a chimpanzee 

sanctuary for the lifetime care of 

chimpanzees no longer needed for 

biomedical research; (9) supports 

training and career development for 

veterinarians engaged in research; (10) 

provides repositories for the storage and 

distribution of genetically altered 

animal models; (11) supports the 

breeding of and accessibility to scarce 

research animals; (12) supports grants 

for the acquisition of state-of-the-art 

instrumentation and integrated 

instrument systems; (13) provides 

support for human tissue and organ 

research resources to meet the needs of 

biomedical researchers, including those 

in academia, government, and industry; 

(14) supports grants to expand, remodel, renovate, or alter existing 

research facilities or to construct new 

research facilities, including to improve 

laboratory animal facilities; and (15) 

coordinates science education activities 

at the NIH, plans, develops, and 

coordinates a comprehensive science 

education program to improve science 

literacy in both adults and children and 

to attract young people to biomedical 

and behavioral science careers; and 

develops and supports grants designed 

to improve life science literacy 

throughout the nation through 

educational programs. 

Division of Comparative Medicine 

(DCM) (N AW92, formerly, HN AW92) 

(1) Provides high-quality, disease-free 

animal models and specialized animal 

research facilities for biomedical 

investigators; (2) supports the 

development of and access to a wide 

range of research models, including 

vertebrate and invertebrate species; (3) 

provides access for biomedical 

researchers to an array of biological 

materials and human biospecimens; (4) 

supports research activities at National 

Primate Research Centers; (5) develops 

and implements policies and provides 

programmatic oversight for the NIH 

Chimpanzee Management Program 

(ChiMP); (6) provides a chimpanzee 

sanctuary for the lifetime care of 

research chimpanzees that are no longer 

needed for biomedical research; (7) 

supports the identification and 

development of new and improved 

animal models for the study of human 

diseases; (8) supports improvement of 

the health and well-being of laboratory 

animals; (9) supports training and career 

development for veterinarians engaged 

in research; (10) provides repositories 

for the storage and distribution of 

genetically altered animal models; and 

(11) supports the breeding of and 

accessibility to scarce research animals. 

Division of Instruments, Infrastructure 

Resources, and Construction (DIIRC) (N 

AW93, formerly, HN AW93) (1) 

Supports programs to expand the 

Nation’s capacity for the conduct of 

biomedical research; (2) supports grants 

for the acquisition of state-of-the-art 

instrumentation and integrated 

instrument systems; (3) provides 

support for human tissue and organ 

research resources to meet the needs of 

biomedical researchers, including those 

in academia, government, and industry; 

and (4) supports grants to expand, remodel, renovate, or alter existing 

research facilities or to construct new 

research facilities, including to improve 

laboratory animal facilities. 

Office of Science Education (OSE) (N 

AW94, formerly, HN AW94) (1) Plans, 

develops, and coordinates a 

comprehensive science education 

program to improve science literacy in 

both adults and children and to attract 

young people to biomedical and 

behavioral science careers; (2) develops 

and directs an extensive set of education 

initiatives in the medical sciences 

targeted to students in grades K–16, 

educators, and the public; (3) advises 

NIH leadership on science education 

issues; (4) conducts, analyzes, and 

assesses research related to science 

education; (5) collaborates within the 

NIH and with public and private sector 

organizations to develop and coordinate 

science education activities; and (6) 

serves as an information resource center 

providing access to educational 

materials and activities related to 

medical science. 

Delegations of Authority Statement: 

All delegations and redelegations of 

authority to officers and employees of 

NIH that were in effect immediately 

prior to the effective date of this 

reorganization and are consistent with 

this reorganization shall continue in 

effect, pending further redelegation. 

Dated: December 30, 2011. 

Francis S. Collins, 

Director. 

[FR Doc. 2012–54 Filed 1–5–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Title: State Court Improvement 

Program. 

OMB No.: 0970–0307. 

Description: From the funds 

appropriated for the Promoting Safe and 

Stable Families Program (PSSF), $10 

million is reserved annually for each of 

three grants to facilitate the State Court 

Improvement Program (CIP) to facilitate 

court improvement in the handling of 

child abuse and neglect cases. 

The Court Improvement Program 

(CIP) is composed of three grants, the 

basic, data, and training grants, 

governed by two separate Program 

Instructions (PIs). The training and data 

grants are governed by the ‘‘new grant’’ 

PI and the basic grant is governed by the 

‘‘basic grant’’ PI. Current PIs require 

separate applications and program 

assessment reports for each grant. Every 

State applies for at least two of the 

grants annually and most States apply 

for all three. As many of the application 

requirements are the same for all three 

grants, this results in duplicative work 

and high degrees of repetition for State 

courts applying for more than one CIP 

grant. 

The purpose of this Program 

Instruction is to streamline and simplify 

the application and reporting processes 

by consolidating the PIs into one single 

PI and requiring one single, 

consolidated application package and 

program assessment report per State 

court annually. These revisions will 

satisfy statutory programmatic 

requirements and reduce both the 

number of required responses and 

associated total burden hours for State 

courts. This new PI also describes 

programmatic and fiscal provisions and 

reporting requirements for the grants, 

specifies the application submittal and 

approval procedures for the grants for 

fiscal years 2012 through 2015, and 

identifies technical resources for use by 

State courts during the course of the 


pmangrum on DSK3VPTVN1PROD with NOTICES